Find out about our latest news and events.

News

Tuesday, 08 Aug 2017

Although significant advances in malaria control have been made in the past few decades, resistance to our current antimalarial drug repertoire threatens control efforts.

Read the article

Events

A young woman smiles in front of tall green and brown reeds under bright sunlight.
1 Jun 2023 | 1pm

Acinetobacter baumannii (Ab) is a clinically important pathogen that has rapidly developed resistance to many antimicrobials.

Read the article
A smiling woman in a lab coat stands in a laboratory setting.
25 May 2023 | 1pm

Autotransporters are a large family of bacterial secreted and/or outer membrane proteins that play key roles in the pathogenesis of many infectious diseases.

Read the article
A woman smiling while sitting on a stone wall with colorful buildings and snow-covered mountains in the background.
18 May 2023 | 4pm

Mutations in the gene encoding the human ATP-binding Cassette (ABC) transporter ABCA4 are implicated in several visual disorders including Stargardt’s disease, an early onset macular dystrophy.

Read the article
A woman wearing safety goggles and a white lab coat in a laboratory setting.
11 May 2023 | 4pm

P-glycoprotein is an ATP Binding Cassette (ABC) transporter, expressed at numerous sanctuary sites protecting the body against xenobiotics. Overexpression of P-glycoprotein in cancer cells is associated with a multidrug resistance phenotype.

Read the article
4 May 2023 | 1pm

Glucose and lactate are critical metabolites for most living organisms. In certain circumstances, such as during the intra-erythrocytic stage of malaria parasites and in the glycolytic cancer cells, glycolysis provides the main energy by breaking down the glucose into lactate.

Read the article
Portrait of a smiling man wearing glasses, a dark coat, and a patterned shirt.
28 Apr 2023 | 3pm

Immunotherapy is a re-emerging alternative to other invasive and debilitating cancer treatments. Monoclonal antibodies that disrupt immune checkpoint molecules, such as PD1 or CTLA4, continually demonstrate great promise.

Read the article